Joost C M Meijers

18PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersHaematologyComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)Haematological tumoursPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 02, 2023
Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior.

Joost C M Meijers, Johanneke van der Harst, Pauline F Marx

|Aug 05, 2022
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra.

Herm Jan M Brinkman, Marleen Zuurveld, Joost C M Meijers

|Jul 11, 2022
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.

Awital Bar Barroeta, J Arnoud Marquart, Kamran Bakhtiari

|May 02, 2022
Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro.

Herm Jan M Brinkman, Frauke Swieringa, Marleen Zuurveld

|Mar 30, 2022
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH.

Nicola J Mutch, Sam Walters, Elizabeth E Gardiner

|Feb 16, 2022
VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.

Marc V A van Moorsel, Geke C Poolen, Cornelis A Koekman

Pageof 3